SubtleMR

SubtleMR aims to improve diagnostic image quality of MRIs by employing a convolutional neural network-based algorithm to either reduce noise or increase sharpness in images from various anatomical regions. Its methodology involves processing DICOM MRI inputs as a Software as a Medical Device (SaMD) through fixed nonlinear filters, with its image enhancement capabilities scientifically validated through retrospective clinical data demonstrating significant improvements in signal-to-noise ratio and structural clarity.

SubtleMR is a Software as a Medical Device (SaMD) designed to enhance Magnetic Resonance Imaging (MRI) images acquired from 1.2 Tesla, 1.5 Tesla, or 3 Tesla scanners. The software utilizes a convolutional neural network (CNN)-based algorithm, which functions as a fixed nonlinear filter, to improve image quality by either reducing noise or increasing image sharpness. The specific algorithmic parameters vary depending on the selected enhancement, though the underlying network designs are similar. Users, typically radiologists in imaging centers, clinics, or hospitals, choose the desired enhancement (noise reduction or sharpness increase) via DICOM Series Description, command line arguments, or environment variables. SubtleMR processes standard DICOM MRI input files from the file system, produces enhanced DICOM images that co-exist with the originals, and has no direct user interface; enhanced images are viewed on existing Picture Archiving and Communication System (PACS) workstations. The software is indicated for reducing image noise in head, spine, neck, and knee MRI scans, and for increasing image sharpness specifically in non-contrast enhanced head MRI. SubtleMR's performance was validated through studies using retrospective clinical data. The noise reduction capability was confirmed by demonstrating an average improvement in signal-to-noise ratio (SNR) of 5% or more in selected regions of interest, while maintaining the visibility of small structures with an average change of 0.5 Likert scale points or less compared to original images. The sharpness increase function was validated by showing improved thickness of anatomical structures and sharpness of structure boundaries in at least 90% of the test datasets. These results confirmed the device's effectiveness in enhancing MRI image quality according to its specified functions.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the convolutional neural network in SubtleMR compare to other image enhancement algorithms in terms of computational efficiency and impact on diagnostic accuracy across different MRI sequences and anatomies?; What specific architectural details of the convolutional neural network are employed for noise reduction versus sharpness increase, and how were these architectures optimized during development?; Are there any known limitations or contraindications for using SubtleMR, such as specific MRI acquisition parameters, patient populations, or pathological conditions where its performance might be suboptimal or lead to artifacts?; How robust is the SubtleMR algorithm to variations in input image quality, MRI scanner vendor, or field strengths beyond the tested 1.2T, 1.5T, and 3T, and what is the expected performance under such varied conditions?; What was the detailed statistical distribution (e.g., range, standard deviation) of the signal-to-noise ratio improvement and Likert scale differences observed in the noise reduction performance test, beyond the reported average values?